Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
European Journal of Medical Research|April 14, 2011
The rainbow cohort: 96 week follow-up of saquinavir-containing regimens in previously antiretroviral therapy (ART)-naive and pre-treated but protease inhibitor (PI)-naive HIV-infected patientsH Knechten, C Stephan, F A Mosthaf, et al.Deutsche Medizinische Wochenschrift (1946)|April 26, 2007
[Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005]M Oette, R Kaiser, M Däumer, et al.AIDS (London, England)|July 14, 2000
Efficacy and safety of twice daily first-line ritonavir/indinavir plus double nucleoside combination therapy in HIV-infected individuals. German Ritonavir/Indinavir Study GroupJ K Rockstroh, F Bergmann, W Wiesel, et al.European Journal of Medical Research|October 19, 2010
Safety and efficacy after switch to a saquinavir-containing antiretroviral regimen in protease inhibitor pretreated HIV-positive patientsC Stephan, H Jaeger, A Carganico, et al.Infection|March 31, 2010
Safety and efficacy of a saquinavir-containing antiretroviral regimen in previously ART-naïve or pretreated but protease inhibitor-naïve HIV-positive patientsH Knechten, C Stephan, F A Mosthaf, et al.HIV Medicine|June 13, 2002
Long-term efficacy and safety of ritonavir/indinavir at 400/400 mg twice a day in combination with two nucleoside reverse transcriptase inhibitors as first line antiretroviral therapyM Lichterfeld, H D Nischalke, F Bergmann, et al.European Journal of Medical Research|May 18, 2007
Consensus recommendation from a group of German experts for the use of enfuvirtide in heavily pretreated HIV patientsB Salzberger, M Däumer, P Gute, et al.European Journal of Medical Research|August 8, 2009
Treatment during primary HIV infection does not lower viral set point but improves CD4 lymphocytes in an observational cohortC Koegl, E Wolf, N Hanhoff, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 2, 2015
Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in EuropeL Marije Hofstra, Nicolas Sauvageot, Jan Albert, et al.Pageof 2